Favet Michael
SEC CIK 1855656 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NPCE | NeuroPace Inc | CEO, Dir | 407.1K | — | — | 2 | 2022-03-08 | 2023-02-21 |
Most active insiders at NPCE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Morrell Martha | Chief MEDICAL Off | — | $399.2K |
| 2 | Kumar Rakhi | Dir | — | — |
| 3 | Ryan Renee | Dir | — | — |
| 4 | Andrade Lisa | Dir | — | — |
| 5 | Williams Patrick F. | CFO | — | — |
| 6 | Becker Joel | CEO, Dir | — | — |
| 7 | Geiger Uri | Dir | — | — |
| 8 | Huennekens R Scott | Dir | — | — |
| 9 | Fischer Frank M | Dir | — | — |
| 10 | LACOB JOSEPH | Dir | — | — |
Favet Michael made no open-market trades at NPCE in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-22 | 2023-02-21 | NPCE | NeuroPace Inc | Favet Michael | CEO, Dir | A - Grant | $0.00 | +225.0K | 407.1K | +124% | $0 | |
| D | 2022-03-08 | 2022-03-08 | NPCE | NeuroPace Inc | Favet Michael | CEO, Dir | A - Grant | $0.00 | +155.1K | 182.1K | +574% | $0 |
Purchase Sale Sale after option exercise All abbreviations